Tafazzin Polyclonal Antibody, 50ul Peptide Modification links TAK1 with TRAF6 and

links TAK1 with TRAF6 and mediates TAK1 activation upon IL-1 stimulation

and participates in suppressing anti-inflammatory responses and insulin sensitizing

The CARL-1 monoclonal antibody reacts with human TWEAK

thus relaxing the supercoils and altering the topology of DNA

The human FAT10 gene

Tafazzin Polyclonal Antibody, 50ul Peptide Modification links TAK1 with TRAF6 andTAZ (tafazzin) encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in TAZ have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is